Cemiplimab-rwlc Approved in Advanced Cutaneous Squamous Cell Carcinoma

被引：0
|
作者：
Schuyler, Devon
机构：
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2018年 / 16卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：707 / 707
页数：1
相关论文
共 50 条
  • [21] Budget impact (BI) analysis of cemiplimab-rwlc for advanced basal cell carcinoma (BCC) after hedgehog inhibitor (HHI) therapy in the United States.
    Paul, Eleanor
    Chen, Chieh-I
    Chowdhury, Zahra
    Xu, Yingxin
    Konidaris, Gerasimos
    LaFontaine, Patrick R.
    Atsou, Kokuvi
    Cope, Shannon
    Philips, Zoe
    Kuznik, Andreas
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [22] PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma
    Migden, M. R.
    Rischin, D.
    Schmults, C. D.
    Guminski, A.
    Hauschild, A.
    Lewis, K. D.
    Chung, C. H.
    Hernandez-Aya, L.
    Lim, A. M.
    Chang, A. L. S.
    Rabinowits, G.
    Thai, A. A.
    Dunn, L. A.
    Hughes, B. G. M.
    Khushalani, N. I.
    Modi, B.
    Schadendorf, D.
    Gao, B.
    Seebach, F.
    Li, S.
    Li, J.
    Mathias, M.
    Booth, J.
    Mohan, K.
    Stankevich, E.
    Babiker, H. M.
    Brana, I.
    Gil-Martin, M.
    Homsi, J.
    Johnson, M. L.
    Moreno, V.
    Niu, J.
    Owonikoko, T. K.
    Papadopoulos, K. P.
    Yancopoulos, G. D.
    Lowy, I.
    Fury, M. G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (04): : 341 - 351
  • [23] Cemiplimab as first intervention for patients with locally advanced cutaneous squamous cell carcinoma.
    Atlas, Jennifer Lynn
    Kanos, Marina
    Symanowski, James Thomas
    Brickman, Daniel
    Forster, Meghan
    Frenkel, Catherine
    Milas, Zvonimir
    Sarantou, Terry
    White, Richard L.
    Amin, Asim
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [24] Treatment option for locally advanced cutaneous squamous cell carcinoma after cemiplimab resistance
    Peller, V.
    Mueller, C.
    Zillikens, H.
    Scheib, C.
    Viktoria, R.
    Roesch, A.
    Ugurel, S.
    Becker, J. C.
    Gutzmer, R.
    Schadendorf, D.
    Livingstone, E.
    Zimmer, L.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 72 - 72
  • [25] Infrequent liver injury from cemiplimab in patients with advanced cutaneous squamous cell carcinoma
    Swanson, Linnea
    Kassab, Ihab
    Tsung, Irene
    Worden, Francis P.
    Fontana, Robert J.
    IMMUNOTHERAPY, 2022, 14 (06) : 409 - 418
  • [26] Management of myelofibrosis and concomitant advanced cutaneous squamous cell carcinoma with ruxolitinib associated with cemiplimab
    Alessio Di Prima
    Andrea Botticelli
    Emilia Scalzulli
    Gioia Colafigli
    Sara Pepe
    Chiara Lisi
    Paolo Marchetti
    Maurizio Martelli
    Robin Foà
    Massimo Breccia
    Annals of Hematology, 2021, 100 : 2117 - 2119
  • [27] Management of myelofibrosis and concomitant advanced cutaneous squamous cell carcinoma with ruxolitinib associated with cemiplimab
    Di Prima, Alessio
    Botticelli, Andrea
    Scalzulli, Emilia
    Colafigli, Gioia
    Pepe, Sara
    Lisi, Chiara
    Marchetti, Paolo
    Martelli, Maurizio
    Foa, Robin
    Breccia, Massimo
    ANNALS OF HEMATOLOGY, 2021, 100 (08) : 2117 - 2119
  • [28] High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma
    Rischin, Danny
    Hughes, Brett G. M.
    Basset-Seguin, Nicole
    Schadendorf, Dirk
    Bowyer, Samantha
    Trabelsi Messai, Sabiha
    Meier, Friedegund
    Eigentler, Thomas K.
    Casado Echarren, Victoria
    Stein, Brian
    Beylot-Barry, Marie
    Dalac, Sophie
    Dreno, Brigitte
    Migden, Michael R.
    Hausschild, Axel
    Schmults, Chrysalyne D.
    Lim, Annette M.
    Yoo, Suk-Young
    Paccaly, Anne J.
    Papachristos, Apostolos
    Nguyen, Jenny-Hoa
    Okoye, Emmanuel
    Seebach, Frank
    Booth, Jocelyn
    Lowy, Israel
    Fury, Matthew G.
    Guminski, Alexander
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (03)
  • [29] Cemiplimab for the Treatment of Advanced Cutaneous Squamous Cell Carcinoma: Appropriate Patient Selection and Perspectives
    Mager, Layna
    Gardeen, Samantha
    Carr, David R.
    Shahwan, Kathryn
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2023, 16 : 2135 - 2142
  • [30] RF-Cemiplimab: First Drug Approved for the Treatment of Metastatic or Unresectable Cutaneous Squamous Cell Carcinoma
    Morgado-Carrasco, D.
    Bosch-Amate, X.
    Fusta-Novell, X.
    Giavedoni, P.
    ACTAS DERMO-SIFILIOGRAFICAS, 2020, 111 (02): : 161 - 163
12345